Artivion (AORT) Shares Outstanding (2010 - 2026)
Artivion's (AORT) quarterly Shares Outstanding (Entity) came in at $50.0 million in Q1 2026, up 13.11% YoY from $44.2 million in Q1 2025, and up 1.32% on a QoQ basis from $49.3 million in Q4 2025.
Artivion (AORT) Shares Outstanding (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Shares Outstanding (Entity) data on file, last reported at $50.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 13.11% year-over-year to $50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.0 million (up 13.11% YoY) and the FY2025 annual result came in at $49.3 million, up 13.58% from the prior year.
- Shares Outstanding (Entity) improved to $50.0 million in Q1 2026, from $49.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $50.0 million in Q1 2026 to a low of $41.7 million in Q1 2022.
- A 5-year average of $44.2 million and a median of $43.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 1.05% — and 2025, when it advanced 13.58%.
- Tracing AORT's Shares Outstanding (Entity) over 5 years: stood at $41.8 million in 2022, then gained by 1.77% to $42.6 million in 2023, then increased by 2.03% to $43.4 million in 2024, then gained by 13.58% to $49.3 million in 2025, then increased by 1.32% to $50.0 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $50.0 million (Q1 2026), $49.3 million (Q4 2025), and $48.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn | 48.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.54 Mn |
| Mar 31, 2026 | 48.07 Mn |
| Dec 31, 2025 | 45.34 Mn |
| Sep 30, 2025 | 47.23 Mn |
| Jun 30, 2025 | 44.30 Mn |
| Mar 31, 2025 | 42.23 Mn |
| Dec 31, 2024 | 41.68 Mn |
| Sep 30, 2024 | 41.84 Mn |
| Jun 30, 2024 | 41.68 Mn |
| Mar 31, 2024 | 41.29 Mn |
| Dec 31, 2023 | 40.74 Mn |
| Sep 30, 2023 | 40.88 Mn |
| Jun 30, 2023 | 40.76 Mn |
| Mar 31, 2023 | 40.43 Mn |
| Dec 31, 2022 | 40.03 Mn |
| Sep 30, 2022 | 40.12 Mn |
| Jun 30, 2022 | 40.03 Mn |
| Mar 31, 2022 | 39.85 Mn |
| Dec 31, 2021 | 38.98 Mn |
| Sep 30, 2021 | 39.09 Mn |